Found: 14
Select item for more details and to access through your institution.
Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Development of a Simple and Objective Prognostication Model for Patients with Advanced Solid Malignant Tumors Treated with Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction: Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Author's Reply to Jia et al.: "BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta‑Analysis".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Comment on: BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta‑Analysis.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Randomized Versus Real-World Evidence on the Efficacy and Toxicity of Checkpoint Inhibitors in Cancer in Patients with Advanced Non-small Cell Lung Cancer or Melanoma: A Meta-analysis.
- Published in:
- 2022
- By:
- Publication type:
- meta analysis